Sermorelin Enhances Insulin Sensitivity in American Males with Type 2 Diabetes: Clinical Trial Insights
Reading Time: 2 minutes Introduction Type 2 diabetes is a prevalent metabolic disorder affecting millions of American males, characterized by insulin resistance and impaired glucose metabolism. Recent research has begun to explore the potential benefits of Sermorelin, a synthetic analog of growth hormone-releasing hormone (GHRH), in managing these conditions. This article discusses the findings of a clinical trial focused on the effects of Sermorelin on insulin sensitivity and glucose metabolism in American males with type 2 diabetes, highlighting its potential as a therapeutic agent. Background on Sermorelin and Its Mechanism Sermorelin acts by stimulating the pituitary gland to release growth hormone (GH), which plays...


